Skip to main content
Clinical Trials/NCT06368193
NCT06368193
Recruiting
Not Applicable

The Neuralert Stroke Monitor Pilot Trial

Neuralert Technologies LLC1 site in 1 country50 target enrollmentDecember 12, 2024
ConditionsStrokeSurgery

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Neuralert Technologies LLC
Enrollment
50
Locations
1
Primary Endpoint
Time to Nursing Response
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of wearing a Neuralert device on each arm. For this pilot trial, we are interested in learning about Wi-Fi connectivity, successful data transmission, integration into clinical workflow, usability and tolerability.

Registry
clinicaltrials.gov
Start Date
December 12, 2024
End Date
May 1, 2027
Last Updated
3 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Neuralert Technologies LLC
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female age ≥ 22 years
  • Admitted or planned admission to one of the participating hospitals and followed by the Cardiothoracic (CT) Surgery or Vascular Surgery services
  • Considered at high risk for stroke while in the hospital based on:
  • Ø Interventions or procedures that are high-risk for stroke performed during the hospitalization, which may include:
  • Intracardiac surgical or endovascular procedures, including valve replacement
  • Ascending aorta or aortic arch surgical or endovascular repair
  • Open surgical or endovascular carotid revascularization
  • Ø Other cardiac procedures along with a high-risk medical history:
  • Age ≥ 80 years · Prior stroke/TIA
  • Hypercoagulable state (i.e., prior clotting events attributed to active malignancy or a diagnosed thrombophilia) requiring lifelong anticoagulation

Exclusion Criteria

  • (all must be no)
  • Any medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study
  • Baseline preoperative asymmetric upper extremity weakness as assessed by the Investigator, defined as a differential in the NIHSS upper extremity motor score between the two arms of \>0
  • Above the wrist amputation
  • Unwilling to provide informed consent or no legally authorized representative willing to provide consent if the patient is unable
  • Currently imprisoned

Outcomes

Primary Outcomes

Time to Nursing Response

Time Frame: Up to 5 days post patient surgery

The time from the nurse receiving an alert to the time they respond after assessing the patient.

Time to Generate Alert

Time Frame: Up to 5 days post patient surgery

The time to successful generation of an alert to staff when asymmetry or low battery is detected.

Secondary Outcomes

  • Number of Strokes Identified(Up to 5 days post patient surgery)
  • Device Tolerability(Up to 5 days post patient surgery)

Study Sites (1)

Loading locations...

Similar Trials